GLP-1 drugs are reshaping consumer habits, pushing food makers and restaurants to rethink portions, menus, and indulgence. Circana forecasts lasting demand for protein-rich, wellness-focused options as health-conscious behaviors persist even beyond GLP-1 use.
The latest Food Institute Fast Break news podcast touches on dollar stores’ continued rise throughout America.
The latest FI Fast Break news podcast touches on one CEO’s alarming prediction regarding the banana supply, plus more trending industry news.
Beverage giants appear to be losing their buzz. Investors are signaling deeper concerns despite steady profits. As GLP-1s and shifting health sentiments rise, the sector’s long-term resilience may be entering a new taste test.
All of a sudden, $5 value meals are everywhere, from fast-food chains to major retailers. Industry insiders say the deals are simply a short-term solution, however.
The latest FI Fast Break news podcast touches on Target’s plans to reduce prices on several items this summer.
Datassential’s Marie Molde breaks down what health and wellness attributes consumers are looking for on restaurant menus in 2024.
The recent rise of Ozempic and other weight-loss drugs started with blowout results that drove shares of their manufacturers higher, then wound up cascading across seemingly disparate sectors. In 2023, Novo Nordisk, the manufacturer of …
The latest Fast Break Food Institute news podcast touches on “The Ozempic Effect” on the food and beverage industry.
